-
Subject Areas on Research
-
22Na+ and 86Rb+ transport in vascular smooth muscle of SHR, Wistar Kyoto, and Wistar rats.
-
8-hydroxy-2-(di-n-propylamino)tetralin-responsive 5-hydroxytryptamine4-like receptor expressed in bovine pulmonary artery smooth muscle cells.
-
A Small Molecule Pyrazolo[3,4-d]Pyrimidinone Inhibitor of Zipper-Interacting Protein Kinase Suppresses Calcium Sensitization of Vascular Smooth Muscle.
-
A comparison of the vasodilating effects of halothane and isoflurane on the isolated rabbit basilar artery with and without intact endothelium.
-
A critical role for chloride channel-3 (CIC-3) in smooth muscle cell activation and neointima formation.
-
A differential role for endocytosis in receptor-mediated activation of Nox1.
-
A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo.
-
A mathematical model of the myogenic response to systolic pressure in the afferent arteriole.
-
A novel inhaled organic nitrate that affects pulmonary vascular tone in a piglet model of hypoxia-induced pulmonary hypertension.
-
A novel role for the cyclin-dependent kinase inhibitor p27(Kip1) in angiotensin II-stimulated vascular smooth muscle cell hypertrophy.
-
A polymorphism of the human matrix gamma-carboxyglutamic acid protein promoter alters binding of an activating protein-1 complex and is associated with altered transcription and serum levels.
-
A system for the direct co-culture of endothelium on smooth muscle cells.
-
A20, a modulator of smooth muscle cell proliferation and apoptosis, prevents and induces regression of neointimal hyperplasia.
-
AIF-1 in the activated smooth muscle cell : spectator or participant?
-
AT2 receptor and vascular smooth muscle cell differentiation in vascular development.
-
Absence of metabolite formation during nitroglycerin-induced relaxation of isolated blood vessels.
-
Activated alpha 2-macroglobulin promotes mitogenesis in rat vascular smooth muscle cells by a mechanism that is independent of growth-factor-carrier activity.
-
Activation in the region of parabrachial nucleus elicits neurogenically mediated coronary vasoconstriction.
-
Activation of NADPH oxidase 1 increases intracellular calcium and migration of smooth muscle cells.
-
Activation of pp60c-src is necessary for human vascular smooth muscle cell migration.
-
Activation of vascular smooth muscle cells by TNF and PDGF: overlapping and complementary signal transduction mechanisms.
-
Adenoviral gene transfer of nitric oxide synthase: high level expression in human vascular cells.
-
Aldosterone increases oxidant stress to impair guanylyl cyclase activity by cysteinyl thiol oxidation in vascular smooth muscle cells.
-
Aldosterone-induced activation of signaling pathways requires activity of angiotensin type 1a receptors.
-
Alpha 1-adrenergic receptor mRNA level is regulated by norepinephrine in rabbit aortic smooth muscle cells.
-
Alpha 1-adrenoceptor activity in arterial smooth muscle following congestive heart failure.
-
Amiprilose hydrochloride inhibits porcine aortic smooth muscle cell proliferation in vitro.
-
An oxidized extracellular oxidation-reduction state increases Nox1 expression and proliferation in vascular smooth muscle cells via epidermal growth factor receptor activation.
-
Angiogenesis-like activity of endothelial cells co-cultured with VEGF-producing smooth muscle cells.
-
Angiotensin AT1B receptor mediates calcium signaling in vascular smooth muscle cells of AT1A receptor-deficient mice.
-
Angiotensin II can regulate gene expression by the AP-1 binding sequence via a protein kinase C-dependent pathway.
-
Angiotensin II type 1 receptor-associated protein is an endogenous inhibitor of angiotensin II type 1 receptor action in cardiac hypertrophy: role in check and balance.
-
Angiotensin II type 1A receptors in vascular smooth muscle cells do not influence aortic remodeling in hypertension.
-
Angiotensin II type 2 receptor mediates vascular smooth muscle cell apoptosis and antagonizes angiotensin II type 1 receptor action: an in vitro gene transfer study.
-
Angiotensin II-induced hypertrophy of rat vascular smooth muscle is associated with increased 18 S rRNA synthesis and phosphorylation of the rRNA transcription factor, upstream binding factor.
-
Angiotensin converting enzyme inhibition and vascular hypertrophy in hypertension.
-
Angiotensin type 2 receptor is expressed in murine atherosclerotic lesions and modulates lesion evolution.
-
Antioxidant and cytotoxic tocopheryl quinones in normal and cancer cells.
-
Antisense oligodeoxynucleotide inhibition of vascular angiotensin-converting enzyme expression attenuates neointimal formation: evidence for tissue angiotensin-converting enzyme function.
-
Antisense oligonucleotides directed at cell cycle regulatory genes as strategy for restenosis therapy.
-
Antisense technology to block autocrine growth factors.
-
Aortic aneurysms: It's all about the stress.
-
Application of magnetic resonance microscopy to tissue engineering: a polylactide model.
-
Arachidonic acid metabolism in cultured aortic endothelial cells. Effect of cAMP and 3-isobutyl-1-methylxanthine.
-
Arterial gene transfer of the TGF-beta signalling protein Smad3 induces adaptive remodelling following angioplasty: a role for CTGF.
-
Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells.
-
Augmented tissue oxygen supply during striated muscle contraction in the hamster. Relative contributions of capillary recruitment, functional dilation, and reduced tissue PO2.
-
Autocrine and paracrine effects of atrial natriuretic peptide gene transfer on vascular smooth muscle and endothelial cellular growth.
-
Autocrine-paracrine mechanisms of vascular myocytes in systemic hypertension.
-
Autoregulation of polypyrimidine tract binding protein by alternative splicing leading to nonsense-mediated decay.
-
Beta-arrestin- but not G protein-mediated signaling by the "decoy" receptor CXCR7.
-
Beta-arrestin-mediated signaling regulates protein synthesis.
-
Bioengineered human acellular vessels for dialysis access in patients with end-stage renal disease: two phase 2 single-arm trials.
-
Biology of intracranial aneurysms: role of inflammation.
-
Biology of vascular calcification in renal disease.
-
Biomechanical effects of flow and coculture on human aortic and cord blood-derived endothelial cells.
-
Blood pressure homeostasis is maintained by a P311-TGF-β axis.
-
Blood pressure-associated polymorphism controls ARHGAP42 expression via serum response factor DNA binding.
-
Blood vessels engineered from human cells.
-
Blood-induced arterial segmental spasm.
-
Bone marrow-derived progenitor cells contribute to experimental choroidal neovascularization.
-
CCR2 deficiency, dysregulation of Notch signaling, and spontaneous pulmonary arterial hypertension.
-
Cell adhesion peptides alter smooth muscle cell adhesion, proliferation, migration, and matrix protein synthesis on modified surfaces and in polymer scaffolds.
-
Cell biology of vascular hypertrophy in systemic hypertension.
-
Cell cycle progression: new therapeutic target for vascular proliferative disease.
-
Cell cycle protein expression in vascular smooth muscle cells in vitro and in vivo is regulated through phosphatidylinositol 3-kinase and mammalian target of rapamycin.
-
Cell cycle-dependent regulation of smooth muscle cell activation.
-
Cellular and molecular mechanisms of coronary artery restenosis.
-
Cerebral blood flow and oxygen delivery during hypoxemia and hemodilution: role of arterial oxygen content.
-
Cerebral cortical arteriolar angiopathy, vascular beta-amyloid, smooth muscle actin, Braak stage, and APOE genotype.
-
Cerebrovascular smooth muscle actin is increased in nondemented subjects with frequent senile plaques at autopsy: implications for the pathogenesis of Alzheimer disease.
-
Cigarette smoke and inflammation: role in cerebral aneurysm formation and rupture.
-
Cigarette smoke modulates vascular smooth muscle phenotype: implications for carotid and cerebrovascular disease.
-
Clinical trials of restenosis after coronary angioplasty.
-
Cloned endothelium derived from autoimmune vascular disease retain structural and functional characteristics of normal endothelial cells.
-
Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral development and the arterial response to injury.
-
Comparison of aortic intima and inner media in young adult versus aging rats. Stereology in a polarized system.
-
Comparison of plasminogen binding and activation on extracellular matrices produced by vascular smooth muscle and endothelial cells.
-
Comparison of relaxation responses to multiple vasodilators in TxA(2)-analog and endothelin-1-precontracted pulmonary arteries.
-
Competing G protein-coupled receptor kinases balance G protein and β-arrestin signaling.
-
Covalently immobilized gradients of bFGF on hydrogel scaffolds for directed cell migration.
-
Cytokine activation of nuclear factor kappa B in vascular smooth muscle cells requires signaling endosomes containing Nox1 and ClC-3.
-
Cytotoxicity of oxidized LDL to porcine aortic smooth muscle cells is associated with the oxysterols 7-ketocholesterol and 7-hydroxycholesterol.
-
DNA transfer into vascular smooth muscle using fusigenic Sendai virus (HVJ)-liposomes.
-
Decellularized native and engineered arterial scaffolds for transplantation.
-
Deletion of the protein kinase A/protein kinase G target SMTNL1 promotes an exercise-adapted phenotype in vascular smooth muscle.
-
Depletion of arterial L-arginine causes reversible tolerance to endothelium-dependent relaxation.
-
Differential effect of nitric oxide on thrombospondin-1-, PDGF- and fibronectin-induced migration of vascular smooth muscle cells.
-
Differential effects of platelet-derived growth factor isotypes on human smooth muscle cell proliferation and migration are mediated by distinct signaling pathways.
-
Direct-contact co-culture between smooth muscle and endothelial cells inhibits TNF-alpha-mediated endothelial cell activation.
-
Distinct roles of E2F proteins in vascular smooth muscle cell proliferation and intimal hyperplasia.
-
Drebrin regulates angiotensin II-induced aortic remodelling.
-
Dual actions of S-nitrosylated derivative of vasoactive intestinal peptide as a vasoactive intestinal peptide-like mediator and a nitric oxide carrier.
-
Effect of antineoplastic agents on smooth muscle cell proliferation in vitro: implications for prevention of restenosis after transluminal angioplasty.
-
Effect of ionizing radiation on thymidine uptake, differentiation, and VEGFR2 receptor expression in endothelial cells: the role of VEGF(165).
-
Effects of ammonium ion derived from bovine endothelial cells upon low density lipoprotein degradation in cultured vascular smooth muscle cells.
-
Effects of cardiopulmonary bypass and circulatory arrest on endothelium-dependent vasodilation in the lung.
-
Effects of treatment with cyclosporine, FK 506, rapamycin, mycophenolic acid, or deoxyspergualin on vascular muscle proliferation in vitro and in vivo.
-
Efficient adenoviral gene transfer to early venous bypass grafts: comparison with native vessels.
-
Elemental composition of Na pump inhibited rabbit aorta VSM cells by electron probe X-ray microanalysis.
-
Endoglin Mediates Vascular Maturation by Promoting Vascular Smooth Muscle Cell Migration and Spreading.
-
Endothelial cell-conditioned medium downregulates smooth muscle contractile protein expression.
-
Endothelial healing in vein grafts: proliferative burst unimpaired by genetic therapy of neointimal disease.
-
Endothelin-1 induces an increase in total protein synthesis and expression of the smooth muscle alpha-actin gene in vascular smooth muscle cells.
-
Endothelium modulation of the effects of nitroglycerin on blood vessels from dogs with pacing-induced heart failure.
-
Enhanced H(2)O(2)-induced cytotoxicity in "epithelioid" smooth muscle cells: implications for neointimal regression.
-
Enhanced vasorelaxation by overexpression of beta 2-adrenergic receptors in large arteries.
-
Ethacrynic acid: acute hemodynamic effects and influence on the in vivo and in vitro response to nitroglycerin in the dog.
-
Evidence for direct local effect of angiotensin in vascular hypertrophy. In vivo gene transfer of angiotensin converting enzyme.
-
Expression of renin-angiotensin system and extracellular matrix genes in cardiovascular cells and its regulation through AT1 receptor.
-
Expression of the AT2 receptor developmentally programs extracellular signal-regulated kinase activity and influences fetal vascular growth.
-
Feasibility of vitrification as a storage method for tissue-engineered blood vessels.
-
Fetuin-A uptake in bovine vascular smooth muscle cells is calcium dependent and mediated by annexins.
-
Fibroblast growth factor 23 is not associated with and does not induce arterial calcification.
-
Focal toxicity of oxysterols in vascular smooth muscle cell culture. A model of the atherosclerotic core region.
-
G protein-coupled receptor kinase 5 in cultured vascular smooth muscle cells and rat aorta. Regulation by angiotensin II and hypertension.
-
G protein-coupled receptor kinase-5 attenuates atherosclerosis by regulating receptor tyrosine kinases and 7-transmembrane receptors.
-
Gender and estrogen supplementation increases severity of experimental choroidal neovascularization.
-
Gene expression of the renin-angiotensin system in human tissues. Quantitative analysis by the polymerase chain reaction.
-
Gene expression programs of human smooth muscle cells: tissue-specific differentiation and prognostic significance in breast cancers.
-
Genetic and functional association of FAM5C with myocardial infarction.
-
Genetic engineering of vein grafts resistant to atherosclerosis.
-
Genetic targeting for cardiovascular therapeutics: are we near the summit or just beginning the climb?
-
Glucose activates mitogen-activated protein kinase (extracellular signal-regulated kinase) through proline-rich tyrosine kinase-2 and the Glut1 glucose transporter.
-
Glutathione peroxidase-deficient smooth muscle cells cause paracrine activation of normal smooth muscle cells via cyclophilin A.
-
Gp91phox contributes to NADPH oxidase activity in aortic fibroblasts but not smooth muscle cells.
-
H(2)O(2)-induced O(2) production by a non-phagocytic NAD(P)H oxidase causes oxidant injury.
-
H19, a developmentally regulated gene, is reexpressed in rat vascular smooth muscle cells after injury.
-
HIV envelope gp120 activates human arterial smooth muscle cells.
-
Hemodynamic parameters and early intimal thickening in branching blood vessels.
-
High cholesterol feeding in C57/Blc6 mice alters expression within the VEGF receptor-ligand family in corporal tissue.
-
Human smooth muscle alpha-actin gene is a transcriptional target of the p53 tumor suppressor protein.
-
Hypoxia inhibits nitric oxide synthesis in isolated rabbit lung.
-
Identification of the enzymatic mechanism of nitroglycerin bioactivation.
-
Identification of two calcium channel receptor sites for [3H]nitrendipine in mammalian cardiac and smooth muscle membrane.
-
Inactivation of the tumour suppressor, PTEN, in smooth muscle promotes a pro-inflammatory phenotype and enhances neointima formation.
-
Increased epidermal growth factor-like ligands are associated with elevated vascular nicotinamide adenine dinucleotide phosphate oxidase in a primate model of atherosclerosis.
-
Increased expression of Nox1 in neointimal smooth muscle cells promotes activation of matrix metalloproteinase-9.
-
Increased vascular smooth muscle contractility in TRPC6-/- mice.
-
Independent beta-arrestin2 and Gq/protein kinase Czeta pathways for ERK stimulated by angiotensin type 1A receptors in vascular smooth muscle cells converge on transactivation of the epidermal growth factor receptor.
-
Induction of angiotensin converting enzyme in the neointima after vascular injury. Possible role in restenosis.
-
Induction of platelet-derived growth factor A-chain and c-myc gene expressions by angiotensin II in cultured rat vascular smooth muscle cells.
-
Inflammatory mechanisms.
-
Inhibition of apoptotic signaling and neointimal hyperplasia by tempol and nitric oxide synthase following vascular injury.
-
Inhibition of vascular smooth muscle cell proliferation, migration, and survival by the tumor suppressor protein PTEN.
-
Inhibitory role of the coronary arterial endothelium to alpha-adrenergic stimulation in experimental heart failure.
-
Interaction of atrial natriuretic polypeptide and angiotensin II on protooncogene expression and vascular cell growth.
-
Interferon regulatory factors regulate interleukin-1beta-converting enzyme expression and apoptosis in vascular smooth muscle cells.
-
Intimal hyperplasia after vascular injury is inhibited by antisense cdk 2 kinase oligonucleotides.
-
Intracellular calcium transients are necessary for platelet-derived growth factor but not extracellular matrix protein-induced vascular smooth muscle cell migration.
-
Investigation of the role of prostaglandins in nitroglycerin-induced relaxation of isolated rabbit blood vessels.
-
Investigations into the role of sulfhydryl groups in the mechanism of action of the nitrates.
-
Irradiation for intimal hyperplasia: implications for peripheral arterial bypass.
-
Kalirin promotes neointimal hyperplasia by activating Rac in smooth muscle cells.
-
Kruppel-like factor 15 is critical for vascular inflammation.
-
Local expression and pathophysiological role of renin-angiotensin in the blood vessels and heart.
-
Locational stereology performed within sampling fields in rat aortic wall, a polarized tissue.
-
Long-term stabilization of vein graft wall architecture and prolonged resistance to experimental atherosclerosis after E2F decoy oligonucleotide gene therapy.
-
Low-level endotoxin induces potent inflammatory activation of human blood vessels: inhibition by statins.
-
MARCH2 promotes endocytosis and lysosomal sorting of carvedilol-bound β(2)-adrenergic receptors.
-
Mas oncogene receptor coupling and peptide specificity in Balb 3T3 and vascular smooth muscle cells.
-
Matrix gla protein is regulated by a mechanism functionally related to the calcium-sensing receptor.
-
Measurement of arterial pressure-dimension relationships in conscious animals.
-
Mechanism of bradykinin-stimulated prostacyclin synthesis in porcine aortic endothelial cells.
-
Medical approaches to prevention of restenosis after coronary angioplasty.
-
Mesothelium contributes to vascular smooth muscle and mesenchyme during lung development.
-
Metabolic cooperation between vascular endothelial cells and smooth muscle cells in co-culture: changes in low density lipoprotein metabolism.
-
Microvascular determinants of blood flow.
-
Mitogenic effect of neuropeptide Y in rat vascular smooth muscle cells.
-
Modulation of phosphatidylinositol 3-kinase signaling reduces intimal hyperplasia in aortocoronary saphenous vein grafts.
-
Molecular mechanism of fibronectin gene activation by cyclic stretch in vascular smooth muscle cells.
-
Molecular mechanisms of vascular renin-angiotensin system in myointimal hyperplasia.
-
Molecular therapies for vascular diseases.
-
Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II.
-
Myogenic constriction of human coronary arterioles.
-
N-acetylcysteine does not modify nitroglycerin-induced tolerance in canine vascular rings.
-
NADPH oxidase 4: walking the walk with Poldip2.
-
Nicotine increases size and severity of experimental choroidal neovascularization.
-
Nitric oxide synthase inhibition irreversibly decreases perfusion in the R3230Ac rat mammary adenocarcinoma.
-
Nitric oxide-generating polymers reduce platelet adhesion and smooth muscle cell proliferation.
-
Nitric oxide-producing polyurethanes.
-
Norepinephrine-induced down regulation of alpha 1 adrenergic receptors in cultured rabbit aorta smooth muscle cells.
-
Novel and effective gene transfer technique for study of vascular renin angiotensin system.
-
Novel in vitro gene transfer method for study of local modulators in vascular smooth muscle cells.
-
Novel small leucine-rich repeat protein podocan is a negative regulator of migration and proliferation of smooth muscle cells, modulates neointima formation, and is expressed in human atheroma.
-
Novel vascular effects of isoprenaline following pacing-induced heart failure in the dog.
-
Nox1 transactivation of epidermal growth factor receptor promotes N-cadherin shedding and smooth muscle cell migration.
-
Overcoming Chronic Rejection-Can it B?
-
Overexpression of G protein-coupled receptor kinase-2 in smooth muscle cells attenuates mitogenic signaling via G protein-coupled and platelet-derived growth factor receptors.
-
Overexpression of human catalase inhibits proliferation and promotes apoptosis in vascular smooth muscle cells.
-
Pathogenesis of varicose veins.
-
Pathophysiology of vascular smooth muscle in renin promoter-T-antigen transgenic mice.
-
Patterns of cardiovascular responses to stress as a function of race and parental hypertension in men.
-
Perfluorooctyl bromide (perflubron) attenuates oxidative injury to biological and nonbiological systems.
-
Pharmacological strategies to prevent restenosis: lessons learned from blockade of the renin-angiotensin system.
-
Phorbol ester effects on alpha 1-adrenoceptor binding and phosphatidylinositol metabolism in cultured vascular smooth muscle cells.
-
Phosphorylation of Nox1 regulates association with NoxA1 activation domain.
-
Phosphorylation of caldesmon by mitogen-activated protein kinase with no effect on Ca2+ sensitivity in rabbit smooth muscle.
-
Phosphorylation of the rRNA transcription factor upstream binding factor promotes its association with TATA binding protein.
-
Photoaffinity labeling of mammalian alpha 1-adrenergic receptors. Identification of the ligand binding subunit with a high affinity radioiodinated probe.
-
Physiological genomics of human arteries: quantitative relationship between gene expression and arterial stiffness.
-
Possible role for vascular cell proliferation in cerebral vasospasm after subarachnoid hemorrhage.
-
Pressure-mediated oligonucleotide transfection of rat and human cardiovascular tissues.
-
Protein kinase C isoforms in human aortic smooth muscle cells.
-
Quantitative enumeration of vascular smooth muscle cells and endothelial cells derived from bone marrow precursors in experimental choroidal neovascularization.
-
Rapamycin inhibits fibronectin-induced migration of the human arterial smooth muscle line (E47) through the mammalian target of rapamycin.
-
Rapid identification of cell-specific, internalizing RNA aptamers with bioinformatics analyses of a cell-based aptamer selection.
-
Readily available tissue-engineered vascular grafts.
-
Reconstruction of rat femoral veins with microvascular prostheses.
-
Redox Activation of Nox1 (NADPH Oxidase 1) Involves an Intermolecular Disulfide Bond Between Protein Disulfide Isomerase and p47phox in Vascular Smooth Muscle Cells.
-
Regions of the 110-kDa regulatory subunit M110 required for regulation of myosin-light-chain-phosphatase activity in smooth muscle.
-
Regulation of 12-lipoxygenase by cytokines in vascular smooth muscle cells.
-
Regulation of the platelet-derived growth factor receptor-beta by G protein-coupled receptor kinase-5 in vascular smooth muscle cells involves the phosphatase Shp2.
-
Relevance and safety of telomerase for human tissue engineering.
-
Remodeling and reparation of the cardiovascular system.
-
Renin synthesis by canine aortic smooth muscle cells in culture.
-
Rho A/Rho kinase: human umbilical artery mRNA expression in normal and pre eclamptic pregnancies and functional role in isoprostane-induced vasoconstriction.
-
RhoA inactivation by S-nitrosylation regulates vascular smooth muscle contractive signaling.
-
Role of AP-1 complex in angiotensin II-mediated transforming growth factor-beta expression and growth of smooth muscle cells: using decoy approach against AP-1 binding site.
-
Role of prostacyclin in the cardiovascular response to thromboxane A2.
-
Role of the sphingosine-1-phosphate receptor EDG-1 in PDGF-induced cell motility.
-
Role of vascular mitogens in subarachnoid hemorrhage-associated cerebral vasculopathy.
-
Secondary heart field contributes myocardium and smooth muscle to the arterial pole of the developing heart.
-
Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia.
-
Smooth Muscle Cell-targeted RNA Aptamer Inhibits Neointimal Formation.
-
Smooth muscle cell growth in photopolymerized hydrogels with cell adhesive and proteolytically degradable domains: synthetic ECM analogs for tissue engineering.
-
Smooth muscle cell migration and proliferation are mediated by distinct phases of activation of the intracellular messenger mitogen-activated protein kinase.
-
Smooth muscle cell rigidity and extracellular matrix organization influence endothelial cell spreading and adhesion formation in coculture.
-
Smooth muscle growth and cholesterol accumulation in atherogenesis.
-
Sox6 as a new modulator of renin expression in the kidney.
-
Statins and nitric oxide donors affect thrombospondin 1-induced chemotaxis.
-
Stem cell factor and c-kit are expressed by and may affect vascular SMCs through an autocrine pathway.
-
Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis.
-
Syndecan-1 regulates vascular smooth muscle cell phenotype.
-
Synergistic effects of matrix nanotopography and stiffness on vascular smooth muscle cell function.
-
TGF-beta through Smad3 signaling stimulates vascular smooth muscle cell proliferation and neointimal formation.
-
TNF-α induces phenotypic modulation in cerebral vascular smooth muscle cells: implications for cerebral aneurysm pathology.
-
TRPV4 Is Required for Hypoxic Pulmonary Vasoconstriction.
-
TRPV4-dependent dilation of peripheral resistance arteries influences arterial pressure.
-
Targeting Gbeta gamma signaling in arterial vascular smooth muscle proliferation: a novel strategy to limit restenosis.
-
Tethered-TGF-beta increases extracellular matrix production of vascular smooth muscle cells.
-
The Actin-Binding Protein Drebrin Inhibits Neointimal Hyperplasia.
-
The CXC chemokine cCAF stimulates precocious deposition of ECM molecules by wound fibroblasts, accelerating development of granulation tissue.
-
The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer.
-
The arterial wall and the atherosclerotic lesion.
-
The coronary artery response to implantation of a balloon-expandable flexible stent in the aspirin- and non-aspirin-treated swine model.
-
The effect of exposure time on microsurgical anastomoses of experimentally crushed arteries.
-
The effects of nicotine on vascular smooth muscle cell chemotaxis induced by thrombospondin-1 and fibronectin.
-
The role of apoptosis in the initiation of vascular calcification.
-
The role of integrins in saphenous vein vascular smooth muscle cell migration.
-
The role of mechanical and humoral factors in growth regulation of vascular smooth muscle and cardiac myocytes.
-
The role of β-arrestin2-dependent signaling in thoracic aortic aneurysm formation in a murine model of Marfan syndrome.
-
The use of micropatterning to control smooth muscle myosin heavy chain expression and limit the response to transforming growth factor β1 in vascular smooth muscle cells.
-
The vascular NADPH oxidase subunit p47phox is involved in redox-mediated gene expression.
-
Thromboxane receptors in smooth muscle promote hypertension, vascular remodeling, and sudden death.
-
Tissue angiotensin system in cardiovascular medicine. A paradigm shift?
-
Toxicity of oxidized low density lipoproteins for vascular smooth muscle cells and partial protection by antioxidants.
-
Transcriptional regulation of matrix gla protein.
-
Transforming growth factor-beta1 inhibition of vascular smooth muscle cell activation is mediated via Smad3.
-
Transplantation of embryonic stem cells into the infarcted mouse heart: formation of multiple cell types.
-
Treatment with rapamycin and mycophenolic acid reduces arterial intimal thickening produced by mechanical injury and allows endothelial replacement.
-
Tumor invasion of muscular vessels predicts poor prognosis in patients with pancreatic ductal adenocarcinoma who have received neoadjuvant therapy and pancreaticoduodenectomy.
-
UDP acts as a growth factor for vascular smooth muscle cells by activation of P2Y(6) receptors.
-
USP20 (Ubiquitin-Specific Protease 20) Inhibits TNF (Tumor Necrosis Factor)-Triggered Smooth Muscle Cell Inflammation and Attenuates Atherosclerosis.
-
Ultrastructural distribution of collagen types I-VI in aging human retinal vessels.
-
Upregulation of osmo-mechanosensitive TRPV4 channel facilitates chronic hypoxia-induced myogenic tone and pulmonary hypertension.
-
Utility of telomerase-pot1 fusion protein in vascular tissue engineering.
-
Vascular Type 1A Angiotensin II Receptors Control BP by Regulating Renal Blood Flow and Urinary Sodium Excretion.
-
Vascular biology: the past 50 years.
-
Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2.
-
Vascular remodeling--the emerging paradigm of programmed cell death (apoptosis): the Francis B. Parker lectureship.
-
Vascular remodeling: mechanisms and implications.
-
Vascular renin-angiotensin system and vascular protection.
-
Vascular renin-angiotensin: a possible autocrine or paracrine system in control of vascular function.
-
Vascular smooth muscle actin is reduced in Alzheimer disease brain: a quantitative analysis.
-
Vascular smooth muscle cell hypertrophy vs. hyperplasia. Autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II.
-
Vascular smooth muscle cell migration induced by domains of thrombospondin-1 is differentially regulated.
-
Vascular smooth muscle responsiveness to noradrenaline and phenylephrine following experimental heart failure in dogs.
-
Vascular tone pathway polymorphisms in relation to primary open-angle glaucoma.
-
Vascular wall renin-angiotensin pathway in control of the circulation. A hypothesis.
-
Vascular-targeted overexpression of G protein-coupled receptor kinase-2 in transgenic mice attenuates beta-adrenergic receptor signaling and increases resting blood pressure.
-
Vasopressin: a new target for the treatment of heart failure.
-
YC-1-mediated vascular protection through inhibition of smooth muscle cell proliferation and platelet function.
-
[Experimental approaches for gene therapy modification of vascular remodeling].
-
eNOS-overexpressing endothelial cells inhibit platelet aggregation and smooth muscle cell proliferation in vitro.
-
{beta}-Arrestin-2 Mediates Anti-apoptotic Signaling through Regulation of BAD Phosphorylation.
-
Keywords of People
-
Gunn, Michael Dee,
Professor of Medicine,
Immunology
-
Hogan, Brigid L. M.,
George Barth Geller Distinguished Professor for Research in Molecular Biology,
Cell Biology
-
Liu, Yutao,
Adjunct Assistant Professor in the Department of Medicine,
Medicine, Medical Genetics
-
Middleton, John Paul,
Professor of Medicine,
Medicine, Nephrology
-
Milano, Carmelo Alessio,
Professor of Surgery,
Surgery, Cardiovascular and Thoracic Surgery
-
O'Connor, Christopher Michael,
Richard Sean Stack, M.D. Distinguished Professor,
Medicine, Clinical Pharmacology
-
Sparks, Matthew A.,
Assistant Professor of Medicine,
Medicine, Nephrology
-
Warner, David Samuel,
Distinguished Distinguished Professor of Anesthesiology, in the School of Medicine,
Neurobiology